rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-7-24
|
pubmed:abstractText |
Peptidyl prolyl cis-trans isomerase (Pin1) isomerizes only phosphorylated serine or threonine residues preceding proline in certain proteins and affects the protein function. Pin1 interacts with many signaling pathways, including Wnt signaling pathway that is crucial for colorectal tumorigenesis. Pin1 promotes cyclin D1 over-expression directly or through the stabilization of beta-catenin. Pin1 is over-expressed in some cancers such as prostate and breast cancers. This study aimed to determine whether Pin1 plays a role in colorectal tumorigenesis through the upregulation of beta-catenin and cyclin D1.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-4790
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright (c) 2006 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
155-60
|
pubmed:meshHeading |
pubmed-meshheading:16847925-Aged,
pubmed-meshheading:16847925-Colorectal Neoplasms,
pubmed-meshheading:16847925-Cyclin D1,
pubmed-meshheading:16847925-Disease Progression,
pubmed-meshheading:16847925-Female,
pubmed-meshheading:16847925-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:16847925-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16847925-Humans,
pubmed-meshheading:16847925-Immunohistochemistry,
pubmed-meshheading:16847925-Lymphatic Metastasis,
pubmed-meshheading:16847925-Male,
pubmed-meshheading:16847925-Neoplasm Invasiveness,
pubmed-meshheading:16847925-Peptidylprolyl Isomerase,
pubmed-meshheading:16847925-Signal Transduction,
pubmed-meshheading:16847925-Survival Rate,
pubmed-meshheading:16847925-beta Catenin
|
pubmed:year |
2006
|
pubmed:articleTitle |
High Pin1 expression is associated with tumor progression in colorectal cancer.
|
pubmed:affiliation |
Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. kuramochi.srg2@tmd.ac.jp
|
pubmed:publicationType |
Journal Article
|